💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Cigna (CI): Can The Stock Surprise This Earnings Season?

Published 05/03/2016, 09:39 PM
Updated 07/09/2023, 06:31 AM
CI
-
DOC_OLD
-
FDUS
-
GARS
-

Cigna Corp. (NYSE:CI) is scheduled to report first-quarter 2016 results on May 6. In the last quarter, this company delivered a 5.06% positive earnings surprise. Let’s see how things are shaping up for this announcement.

Factors Influencing this Past Quarter

Cigna is likely to benefit from its strong membership driven by organic growth in the Middle Market, International, Select and Medicare segments. Exposure to the Medicare Advantage market is expected to add to the upside.

Evolving Global Supplemental Benefits should also support Cigna’s results as the insurer has a strong market position and strategic investments in the same.

However, restrictions to market or sell Medicare Advantage policies or Part D drug plans to new clients may weigh on its top line. Adverse effect of forex and higher expenses are expected to taper the bottom line.

With respect to the surprise trend, Cigna surpassed expectations in each of the last four quarters, with an average beat of 5.69%.

The company’s share price has been fluctuating over the last few days. We wait to see how the stock reacts to the quarter’s results.

Earnings Whispers

Our proven model does not conclusively show that Cigna will beat the Zacks Consensus Estimate in the first quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy) or at least 2 (Buy) or 3 (Hold) for this to happen. But this is not the case here as elaborated below.

Zacks ESP: Cigna has an Earnings ESP of +0.46%. This is because the Most Accurate estimate stands at $2.18 while the Zacks Consensus Estimate is pegged lower at $2.17.

Zacks Rank: Cigna has a Zacks Rank #4 (Sell). The Sell-rated stocks (Zacks Rank #4 or 5) should never be considered going into an earnings announcement.

Stocks to Consider

Here are some companies that you may want to consider as these have the right combination of elements to post an earnings beat this quarter:

Physicians Realty Trust (NYSE:DOC) has an Earnings ESP of +4.35% and a Zacks Rank #3. The company is scheduled to report first-quarter earnings results on May 5.

Fidus Investment Corporation (NASDAQ:FDUS) has an Earnings ESP of +2.44% and a Zacks Rank #1. The company is scheduled to report first-quarter earnings results on May 5.

Garrison Capital Inc (NASDAQ:GARS) has an Earnings ESP of +6.25% and a Zacks Rank #3. The company is scheduled to report first-quarter earnings results on May 9.



GARRISON CAPITL (GARS): Free Stock Analysis Report

CIGNA CORP (CI): Free Stock Analysis Report

PHYSICIANS RLTY (DOC): Free Stock Analysis Report

FIDUS INVESTMNT (FDUS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.